Evolution of Clinical Trials in China: From GCP 2003 to NMPA Reforms
Evolution of Clinical Trials in China: From GCP 2003 to NMPA Reforms How China’s Clinical Trial Landscape Transformed from GCP 2003 to NMPA Reforms Introduction Clinical trials in China have undergone a dramatic transformation over the past two decades. From the initial implementation of Good Clinical Practice (GCP) standards in 2003 to the sweeping reforms…
Read More “Evolution of Clinical Trials in China: From GCP 2003 to NMPA Reforms” »